I maintain a Neutral view on CSL Limited due to the mixed prospects for its flu vaccine (Seqirus) and plasma therapy (Behring ...

Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s ...

Companies of above-average quality don’t trade cheaply too often. When they do, it’s usually because investors are concerned ...

The ASX 200 biotech stock has lost 9% of its value since the start of the new year. The post Why is the CSL share price ...

CSL shares will pay a 9% higher interim dividend of US$1.30 per share on 9 April. Here's when the ASX healthcare giant will ...

How much will CSL shareholders receive in dividends? CSL will pay a dividend of US$1.30 per share unfranked on 9 April. The FY25 interim dividend is 9% higher than the FY24 interim dividend.

CSL Limited ( ASX:CSL ) stock is about to trade ex-dividend in 2 days. The ex-dividend date is usually set to be ...

Pioneer Legal and AZB & Partners are advising Chemplast Sanmar Limited (CSL) and its subsidiary, Chemplast Cuddalore Vinyls ...

Carlisle Companies Incorporated (NYSE:CSL) today published its 2024 Annual Report, highlighting Carlisle’s strategic pivot to a pure play building products company as well as progress against Vision ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or CSL Limited Sponsored ADR (CSLLY). But which of these two ...